Meprin β: A novel regulator of blood–brain barrier integrity

Abstract

The metalloprotease meprin β (Mep1b) is capable of cleaving cell-adhesion molecules in different tissues (e.g. skin, kidney and intestine) and is dysregulated in several diseases associated with barrier breakdown (Alzheimer´s disease, kidney disruption, inflammatory bowel disease). In this study, we demonstrate that Mep1b is a novel regulator of tight junction (TJ) composition and blood–brain barrier (BBB) integrity in brain endothelium. In Mep1b-transfected mouse brain endothelial cells (bEnd.3), we observed a reduction of the TJ protein claudin-5, decreased transendothelial electrical resistance (TEER) and an elevated permeability to paracellular diffusion marker [¹⁴C]-inulin. Analysis of global Mep1b knock-out (Mep1b^−/−) mice showed increased TJ protein expression (claudin-5, occludin, ZO-1) in cerebral microvessels and increased TEER in cultivated primary mouse brain endothelial compared to wild-type (wt) mice. Furthermore, we investigated the IgG levels in cerebrospinal fluid (CSF) and the brain water content as additional permeability markers and detected lower IgG levels and reduced brain water content in Mep1b^−/− mice compared to wt mice. Showing opposing features in overexpression and knock-out, we conclude that Mep1b plays a role in regulating brain endothelial TJ-proteins and therefore affecting BBB tightness in vitro and in vivo.

Keywords

Blood–brain barrier meprin β tight junctions brain endothelium brain water content

Introduction

The metalloprotease Mep1b is a member of the astacin family of zinc endopeptidases and exhibits a unique structure and specificity among all extracellular proteases. Originally found to be highly expressed in intestine and kidney, recently, a much broader expression pattern has been detected implicating functions in several different biological processes such as inflammation and neurodegeneration.¹

Mep1b is predominantly membrane bound but can also be released from the cell surface by proteolytic shedding.² The protease has been implicated in connective tissue formation and detachment of the intestinal mucus layer for proper barrier function, but the physiological roles of Mep1b are in many cases still elusive.³ As an extracellular protease Mep1b is capable of cleaving extracellular matrix components and cell-adhesion molecules in different tissues such as kidney (E-cadherin and tenascin-C) and skin (E-cadherin and desmogleins).^1,2,4,5 Previously, we reported elevated Mep1b RNA levels in human brain compared to most other organs, indicating that Mep1b could also be important for cerebral cell–cell adhesion properties.⁶ The ability of cleaving cell-adhesion molecules and the elevated transcription levels in brain, let us hypothesize whether Mep1b could have an effect on TJs in brain endothelium and, therefore, also on the integrity of the BBB.

The BBB regulates the molecular exchange between blood and brain and contributes to the maintenance of central nervous system (CNS) homeostasis, which is essential for normal neuronal function.⁷ Protecting the CNS from pathogens and toxic agents, the BBB compromises blood vessel endothelial cells, pericytes and astrocytes, termed the neurovascular unit.^8,9 The endothelial cells are linked by TJs that are formed by transmembrane adhesion proteins like claudin-5, occludin and their cytoplasmic-associated protein Zonula occludens 1 and 2 (ZO-1, ZO-2). The TJs regulate the paracellular passage of polar solutes and macromolecules across the barrier and are responsible for the high electrical resistance and the low endothelial permeability by closing the paracellular space of adjacent cells.^7,8,10

A breakdown of the BBB includes a structural disruption of the TJs and increased paracellular permeability, which is a common feature of several CNS disorders, including acute and chronic neurodegenerative diseases like Alzheimer’s disease (AD), Parkinson disease (PD), Huntington disease (HD), amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).^7,8,11 This can lead to an extensive influx of hematogenous fluid into the extravascular space, resulting in an increased brain water content and swelling/edema.^7,8,11,12 Additionally, immune cells and mediators that are normally separated by the BBB from the CNS gain access to the brain, causing neuroinflammation.^7,8,11,13 For many of these neurodegenerative diseases like AD or MS, BBB breakdown has been associated with an increased activity of matrix metalloproteinases such as MMP-9 in CSF or in pericytes and endothelial cells compromising the BBB.^14,15

In this study, we examined the function of the metalloprotease Mep1b for the integrity of the BBB in vitro and in vivo.

Material and methods

Mice

Mature congenic global Mep1b^−/−mice on a C57Bl/6 background, as previously described¹⁶ and wt controls were kept in the Central Animal Facility of the University Medical Center (ZVTE) of the Johannes Gutenberg-University of Mainz under a 12-h light-dark cycle with water and rodent chow ad libitum. Our experiments were permitted under registration G16-1-076 by the Landesuntersuchungsamt Koblenz, Rhineland-Palatinate. The permit contains the approval of the §15 Commission of Rhineland-Palatinate according to the German Animal Welfare Act. All animals were conducted in the license for housing and breeding laboratory animals (41a/177-5865-§11 ZVTE) from the local authorities (Kreisverwaltung Mainz-Bingen, Rhineland-Palatinate). The handling of the mice and the experimental procedures were conducted in accordance with European (EU-Directive EU/2010/63), national (German Animal Welfare Act), and institutional guidelines (SOP regulations for laboratory animals, Medical University Mainz) for animal care. The authors confirm compliance with the ARRIVE guidelines (Animal Research: Reporting in Vivo experiments) regarding the report of the animal experiments.

Cell culture and antibodies

The following antibodies were used: rabbit anti-claudin-5 and mouse anti-occludin (both from Invitrogen, Darmstadt, Germany), rabbit anti-Zo-1 (Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-Mep1b (self-made, polyclonal against a peptide of the extracellular domain), rabbit anti-β-actin and secondary HRP-conjugated antibodies against rabbit (both from Sigma-Aldrich, Schnelldorf, Germany) and mouse (Jackson Immuno Research, Cambridgeshire, UK). For a detailed description of all primary and secondary antibodies, see Supplemental Table 1. All cells were cultured at 37°C, 5% CO₂ atmosphere and 95% relative humidity. Mouse brain bEnd.3 endothelial cells (ATCC, Manassas, VA, USA) such as the packaging cell line GP-293 (Clontech, Mountain View, CA, USA) were grown in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Darmstadt, Germany) high glucose medium containing 10% fetal calf serum (FCS) and 100 U/ml penicillin/streptomycin (Gibco, Darmstadt, Germany).

Generation of stably overexpressing meprin β bEnd.3 cells

To generate a Mep1b-containing retrovirus, the packaging cells GP-293 were transfected by polyethylenimine (PEI) (Sigma-Aldrich, Schnelldorf, Germany) with a pLBCX Mep1b construct according to the manufacturer’s instructions. Six hours post-transfection, the medium was changed and viruses were collected for another 24 h. The virus infected the interesting target cells bEnd.3 in the presence of 40 μg/mL polybrene (Sigma-Aldrich, Schnelldorf, Germany) for 24 h. Then, the infected bEnd.3 cells were selected with 5 μg/mL blasticidin (Invitrogen, Carlsbad, CA, USA) for two weeks. In further experiments, a clone with high expression of Mep1b was used. In all approaches, we seeded 50,000 cells per cm² and experiments were performed five days after seeding when cells had reached confluency.

Isolation and cultivation of primary mouse and porcine brain capillary endothelial cells

Primary mouse brain capillary endothelial cells (pMBCECs) were isolated from 8- to 12-week-old global Mep1b^−/− and wt mice according to a standard protocol as described previously with minor modifications.¹⁷ In brief, mice were sacrificed by cervical dislocation, the cortices were pooled and tissue was mechanically dissociated, followed by a digest with a mixture of 0.75 mg/ml collagenase CLS2 (Worthington, Lakewood, NJ, USA) and 10 U/ml DNaseI (Sigma-Aldrich, Schnelldorf, Germany) in DMEM (Gibco, Darmstadt, Germany) performed at 37°C on a shaker set at 1000g for 1 h. The pellet was resuspended in 20% BSA-DMEM (w/v) and centrifuged at 1000g for 20 min to remove myelin. The pellet was further digested with 1 mg/mL collagenase-dispase (Roche, Mannheim, Germany) and 10 U/mL DNAse in DMEM at 37°C on a shaker for 1 h. Endothelial capillaries were separated on a 33% continuous Percoll (GE Healthcare, Munich, Germany) gradient, collected, and plated on 24-well transwell filters (pore size, 0.4 μm; surface area, 33.6 mm²; Greiner Bio-One) coated with 0.4 mg/mL collagen IV and 0.1 mg/mL fibronectin (both from Sigma-Aldrich, Schnelldorf, Germany). Cultures were maintained in DMEM supplemented with 20% plasma-derived bovine serum (First Link, Birmingham, UK), 100 U/mL penicillin and 100 μg/mL streptomycin, 2 mM L-glutamine (all from Gibco, Darmstadt, Germany), 4 μg/mL puromycin (Alexis, Loerrach, Germany) and 30 µg/ml endothelial cell growth supplement (Sigma-Aldrich, Schnelldorf, Germany) at 37°C and 5% CO₂.

Cells were cultured in the cellZscope device, in which TEER and capacitance were monitored over time. After four days in culture, puromycin was withdrawn and when cells reached confluency and the capacitance was around 1 μF/cm², culture medium was removed and serum-free DMEM (Gibco, Darmstadt, Germany) medium containing 1 mM l-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin was supplemented; 550 nM hydrocortisone (Sigma-Aldrich, Schnelldorf, Germany) was added to induce high TEER for 24 h.

Primary porcine brain endothelial cells were isolated as described previously.¹⁸ Cells were plated in Earle’s media 199 (FG0615, Biochrom) supplemented with 0.7 mM L-glutamine, 10 mg/ml penicillin/streptomycin and 10% FCS on 60 mm plates coated with 0.4 mg/mL collagen IV and 0.1 mg/mL fibronectin (both from Sigma-Aldrich, Schnelldorf, Germany). Puromycin was withdrawn after four days in culture. Cells were used for studies when they were confluent.

Treatment of cells with soluble Mep1b

Recombinant Mep1b was generated as described elsewhere.² After confluence of bENd.3 or primary porcine brain endothelial cells, recombinant Mep1b was added to serum-free media. As a control, cells incubated with recombinant protein in the presence of actinonin (10 μM) or without Mep1b were analyzed. After 24-h incubation, cells were washed and lysed as described below.

Determination of ventricle size

Eight-to-twelve-week-old mice were transcardially perfused with PBS containing 10 U/ml Heparin and brain was harvested and put in Roti®-Histofix (Carl Roth) containing 4% PFA for 24 h. After that, brains were put in 30% sucrose until they sunk and then embedded in cryomedia and frozen on dry ice; 60 µm coronal sections were cut with a cryostat and stained with Nissl. In similar coronal sections, the size of the lateral ventricles and third ventricle was examined under a microscope (Olympus CKX41).

Transendothelial electrical resistance studies

The integrity of bEnd.3 and pMBCEC cell monolayers was analyzed by the measurement of TEER. Cells (15,000 cells/insert) were seeded in collagen-coated 24-transwell inserts (pore size, 0.4 μm; surface area, 33.6 mm²; Greiner Bio-One, Frickenhausen, Germany) and placed into the cellZscope device (nanoAnalytics, Münster, Germany). TEER and capacitance of cells were measured automatically every hour by impedance spectroscopy. When capacitance values were between 1.0 and 0.8 μF/cm², indicating a confluent monolayer of cells, the TEER values were measured. Additionally, for bEnd.3 cells, the permeability to [C¹⁴]-inulin (Perkin-Elmer, Waltham, MA, USA) was analyzed as described previously.¹⁹

Cerebral vessel isolation

Cerebral microvessels for tight junction protein analysis were isolated from parenchymal brain tissue of 8- to 12-week-old global Mep1b^−/− and wt mice as described previously.¹⁸ Whole brain vasculature isolation was done according to a similar protocol. First, mouse brains were harvested and were pooled, meninges were removed, and the tissue was mechanically dissociated in ice-cold phosphate-buffered saline (PBS) containing 2% fetal bovine serum (FBS) using a stainless steel razor blade followed by vigorously pipetting. After centrifugation at 1000g for 20 min, the pellet was resuspended in 20% BSA-DMEM (w/v) and centrifuged at 1000g for 20 min to separate the vasculature from the rest of the brain. The capillary pellet located at the bottom of the tubes was collected, washed with PBS and snap frozen for enzymatic activity assays.

CSF isolation

Samples of CSF of 8- to 12-week-old global Mep1b^−/− and wt mice were taken by puncture of the cisterna magna as described previously.²⁰ After centrifugation at 900 × g for 10 min at 4°C, 4 μl of cell-free CSF were diluted in water and mixed with equal amounts of 2× RotiLoad (Carl Roth, Karlsruhe, Germany). The IgG protein levels in CSF were determined by Western blot analysis using a secondary anti-mouse antibody.

Cell extraction and Western blot analysis

BEnd.3 cells were washed with cold PBS and scraped off from culture dishes. Both bEnd.3 and brain vessel extracts were lysed in NP40 lysis buffer supplemented with complete protease inhibitors (Roche, Mannheim, Germany) for 20 min. Extracts were centrifuged at 18,000g for 20 min at 4°C in a microcentrifuge. Protein concentrations were determined by BCA protein assay (Pierce Chemicals, Dallas, Texas, U.S.A.). Equal amounts of total proteins were incubated with RotiLoad (Carl Roth, Karlsruhe, Germany) and heat-denatured at 95°C for 5 min. Equal amounts of protein from each sample (bEnd.3, brain vessels) or equal volumes of CSF were separated by NuPage on 4-12 Bis-Tris gels (Invitrogen, Darmstadt, Germany), transferred to nitrocellulose membranes (Millipore, Bedford, MA, USA) and then blocked for 1 h in 5% nonfat dry milk in TBST (20 mM Tris, 137 mM NaCl, 0,1% (v/v) Tween-20 (Carl Roth, Karlsruhe, Germany)). After incubation with appropriate primary and secondary antibodies, proteins were detected using enhanced chemiluminescence (Millipore, Schwalbach, Germany) by using the LAS-3000mini (Fujifilm, Dusseldorf, Germany).

Brain water content

Mice (38 to 42 weeks old) were anesthetized, sacrificed by cervical dislocation, and the brain was immediately removed, weighed and then dried overnight at 100°C. The dried brain was re-weighed and the brain water content calculated as (wet weight- dry weight) × 100/wet weight. The net change in brain water in global Mep1b^−/− mice was normalized to wild-type controls.

Activity assays

To quantify Mep1b proteolytic activity towards the extracellular loops of occludin, we designed two quenched fluorogenic peptides comprising the corresponding amino acid sequences from murine occludin, a fluorophore (7-methyloxycoumarin-4-yl (mca)) and a quencher (K-ε-2,4-dinitrophenyl [dnp]) (peptide 1: mca-GYGGYTDPRAA-K-ε-dnp; peptide 2: mca- GLYVDQYLYHYSVVDPQE-K-ε-dnp; Genosphere Biotechnologies). For in vitro activity measurements, peptides were used in a final concentration of 20 μM incubated with 20 nM or 50 nM recombinant Mep1b²¹ in 100 μl total volume in 96-well plates. In order to quantify Mep1b activity in tissue lysates (150 μg in 1% Triton-X/PBS lysis buffer), a highly specific Mep1b fluorogenic peptide substrate (mca-EDEDED-K-ε-dnp; Genosphere Biotechnologies) in a final concentration of 50 μM was used. Fluorescence intensities were detected at 37°C every 30 s for 120 min using a spectrophotometer (Tecan). For data analysis, slope of equal linear activity range was compared.

Statistical analysis

All graphs and statistical analyses were prepared using GraphPad Prism 8 software (GraphPad, La Jolla, CA, USA). Data were analyzed by unpaired t-test or one-way ANOVA followed by Tukey’s post hoc test. P < 0.05 was considered as statistically significant. Significance values were as follows: *P ≤ .05; **P ≤ .01; and ***P ≤ .005.

Results

The expression of TJ protein claudin-5 is decreased in Mep1b-overexpressing endothelial bEnd.3 cells

Since Mep1b is able to cleave cell-adhesion molecules in different tissues (e.g. skin, kidney and intestine)^1,2,4,5 is dysregulated in various diseases^22–24 and shows elevated transcription levels in the brain compared to most other organs,⁶ we investigated whether Mep1b has an effect on TJ function in brain endothelium. Therefore, we generated stable overexpressing Mep1b endothelial cells (bEnd.3) which physiologically express TJ proteins (e.g. claudin-5). In Mep1b overexpressing bEnd.3 cells, we observed a significant reduction of full-length claudin-5 protein by approximately 50% compared to control bEnd.3 cells, suggesting that overexpression of Mep1b results in an altered TJ composition in vitro (Figure 1(a) and (b)).

Figure 1.

Decreased expression of claudin-5 and impaired barrier integrity in Mep1b-overexpressing bEnd.3 cells. (a) Representative immunostaining of Mep1b and claudin-5 in lysates of control bEnd.3 cells and Mep1b-overexpressing bEnd.3 cells. Anti-β actin is shown as loading control. Kidney lysates of Mep1b wt (*wt) and Mep1b^−/− (*ko) mice were used as Mep1b positive and negative control. (b) Claudin-5 levels were quantified by densitometric analysis of Western blots. Intensities of bEnd.3 cells were set as 100%. Data represent dot plots and mean ± standard deviation of n = 5 (bEnd.3) and n = 5 (bEnd.3 + Mep1b) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001. (c) Mep1b overexpressing and control bEnd.3 cells were cultivated on transwell inserts in the cellZcope device. TEER and capacitance of cells were measured over time by impedance spectroscopy. (d) TEER measurement of Mep1b overexpressing bEnd.3 cells compared to control bEnd.3 cells. TEER values of bEnd.3 cells were set as 100%. Maximum TEER values were > 50 Ωcm² (bEnd.3) and >30 Ωcm² (bEnd.3 + Mep1b). One representative set of data dot plots and mean ± standard deviation of n = 12 (bEnd.3) and n = 12 (bEnd.3 + Mep1b) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001. (e) Apparent permeability (P_app) of [¹⁴C]-inulin of control bEnd.3 cells compared with Mep1b overexpressing bEnd.3 cells. Data represent dot plots and mean ± standard deviation of n = 11 (bEnd.3) and n = 11 (bEnd.3 + Mep1b) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001. In the acceptor compartment of the transwell, naive bEnd.3 cells showed a mean permeability of 0.4965% of the input inulin added to the donor compartment after 1 h and Mep1b-transfected bEnd.3 cells 0.63%.

Overexpression of Mep1b leads to an impaired barrier integrity in bEnd.3 cells

TJs dictate the paracellular permeability of the BBB.²⁵ As we observed that overexpression of Mep1b results in reduced levels of the TJ protein claudin-5 in vitro, we examined whether these decreased TJ protein levels also affect the barrier integrity. Hence, Mep1b overexpressing bEnd.3 cells and the control mock-transfected bEnd.3 cells were seeded on standard transwell inserts and TEER and capacitance were measured by impedance spectroscopy using a cellZcope device (Figure 1(c)). High TEER values are associated with greater tightness of the endothelium and lower permeability of the barrier, and therefore the TEER value acts as an appropriate indicator for BBB integrity.^25,26 When Mep1b-overexpressing and mock transfected bEnd.3 cells showed similar capacitance values, indicating that cells were confluent, we observed a significant reduction of TEER values by approximately 40% in the Mep1b-overexpressing bEnd.3 cells compared to the controls (Figure 1(d)).

To use a second marker for barrier integrity, we analyzed the permeability of radiolabeled [C¹⁴]-inulin in Mep1b overexpressing bEnd.3 cells compared to mock-transfected bEnd.3 cells. The small hydrophilic substance [C¹⁴]-inulin is a suitable marker for paracellular diffusion, as it is neither a ligand for influx or efflux transporters, endothelial receptors, nor a substrate for endothelial enzymes.²⁵ The Mep1b overexpressing bEnd.3 cells showed an approximately 30% higher permeability to [C¹⁴]-inulin compared to controls (Figure 1(e)). Taken together, these data provide evidence that overexpression of Mep1b in bEnd.3 cells not only results in a decrease of TJ protein claudin-5, but furthermore leads to an impaired barrier integrity in these cells, which is apparent in reduced TEER and elevated permeability to [C¹⁴]-inulin.

Increased TJ protein levels in cerebral microvessels of Mep1b^−/− mice

To investigate whether the Mep1b-mediated decrease of claudin-5 levels observed in bEnd.3 cells is also of in vivo relevance, we isolated and characterized brain microvessels from global Mep1b^−/− and wt mice. The microvessels were analyzed for the composition of TJ proteins claudin-5, occludin and ZO-1. In contrast to the Mep1b overexpression in bEnd.3 cells, we observed increased TJ protein levels in murine cerebral microvessels lacking Mep1b (Figure 2(a) to (d)). We detected a significant increase of claudin-5 expression by approximately 60% compared to wt controls (Figure 2(b)). Additionally, the levels of the cytoplasmic accessory TJ protein ZO-1 were affected by the lack of Mep1b and showed an about 100% increased abundance compared to wt mice (Figure 2(d)). Likewise, the levels of the TJ protein occludin were also elevated in Mep1b^−/− mice by approximately 100% (Figure 2(c)).

Figure 2.

Increased TJ protein levels in cerebral microvessels of Mep1b^−/− mice. Microvessels derived of Mep1b^−/− and wt mice were isolated and subjected to SDS-PAGE following immunostaining. (a) Representative immunostaining of TJ proteins ZO-1, occludin and claudin-5 in cerebral microvessels isolated from brains of Mep1b^−/− and wt mice. Anti-β actin is shown as loading control. (b–d) Expression levels of TJ proteins ZO-1 (d), occludin (c) and claudin-5 (b) were quantified by densitometric analysis of Western blots. Intensities of cerebral microvessels isolated from Mep1b wt mice were set as 100%. Data represent dot plots and mean ± standard deviation of n = 7 (Mep1b wt) and n = 7 (Mep1b ko) (b), n = 5 (Mep1b wt) and n = 5 (Mep1b ko) (c), n = 4 (Mep1b wt) and n = 4 (Mep1b ko) (d) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001. (e) Activity assay performed with 150 µg of brain vessels and kidney lysates of Mep1b^−/− and wt mice, incubated with 50 µM of a specific Mep1b fluorogenic peptide substrate in 100 µl total volume in 96-well plates. Fluorescence intensities were detected at 37°C every 30 s for 120 min using a spectrophotometer. Intensities of Mep1b^−/− lysates were set as 1.0. For data analysis, slope of equal linear activity range was compared. Data are presented as mean ± standard deviation and statistical analyses were assessed by one-way ANOVA followed by Tukey’s post hoc test from four replicates. *P < 0.05, **P < 0.01, ***P < 0.001.

We tried to analyze Mep1b expression in isolated microvessels of global Mep1b^−/− and wt mice but were not able to see specific bands corresponding to the molecular weight of Mep1b with several commercially available and in-house-made antibodies. In order to see whether Mep1b is expressed in cells compromising the neurovascular unit, we therefore used an indirect approach. We isolated brain vessels from Mep1b^−/− and wt mice and analysed the enzymatic activity of Mep1b with Mep1b-specific fluorogenic-quenched substrates. We used kidney lysates of Mep1b^−/− and control mice as activity controls in this assay because kidneys show the highest Mep1b expression amongst organs. In brain vessels of wt mice, we observed a slightly but significantly higher Mep1b activity compared to the Mep1b^−/−, suggesting that there is low Mep1b expression in brain vessels despite not being able to detect it in Western blot analyses with various antibodies (Figure 2(e)).

Of note, in Western Blot analysis the band size detected for occludin was shifted upwards in the Mep1b^−/− mice indicating an influence of Mep1b on proteolytic cleavage of occludin under homeostatic conditions in wt mice (Figure 2(a)). Concerning the molecular mass of the detected occludin bands using an antibody against the C-terminus of the protein, this cleavage occurs most likely in the first and/or second extracellular loop. To further investigate whether occludin may be a direct substrate of Mep1b, we designed quenched fluorogenic peptides comprising the amino acid sequences of the two extracellular loops of occludin (Figure 3(a)). Indeed, peptide 2 corresponding to the second extracellular loop of occludin was effectively cleaved by Mep1b, whereas peptide 1 referring to the first extracellular loop was not (Figure 3(b) and (c)). This result demonstrates the specificity of Mep1b cleavage, since only one of the potential cleavage sites was readily detected and processed by Mep1b. However, further downstream effects of Mep1b on other proteases, such as ADAMs (PMID 31381863)²⁷ that cleave occludin in vivo, cannot be excluded.

Figure 3.

A peptide cleavage assay shows specific cleavage of a peptide corresponding to the second extracellular loop of occludin by proteolytic activity of Mep1b. (a) Schematic representation of occludin. (b, c) Mep1b proteolytic activity assay towards the extracellular loops of occludin. Quenched fluorgenic peptides compromising the amino acid sequence of the first (b) and second (c) extracellular loop of occludin were designed. For in vitro activity measurement, peptides were used in a final concentration of 20 µM incubated with 20 nM or 50 nM recombinant Mep1b in 100 µl total volume in 96-well plates. Fluorescence intensities were detected at 37°C every 30 s for 120 min using a spectrophotometer. Intensities of loop peptides without Mep1b were set as 1.0. For data analysis, slope of equal linear activity range was compared. Data represent dot plots and mean ± standard deviation of three independent experiments. For statistical analyses, one-way ANOVA followed by Tukey’s post hoc test was used. *P < 0.05, **P < 0.01, ***P < 0.001.

Elevated TEER in primary mouse brain endothelial cells from Mep1b^−/− mice

In vitro models using monolayers of primary endothelial cells provide significant insight into BBB physiology by allowing the measurement of molecule transport^17,18 or barrier integrity.^19,28 TEER is an indicator for tightness and integrity of the BBB and is directly dependent on TJ formation. Since, we observed elevated TJ protein levels in cerebral microvessels from global Mep1b^−/− mice, we investigated the barrier integrity in primary mouse brain capillary endothelial cells (pMBCECs). Therefore, we isolated pMBCECs from Mep1b^−/−and wt mice and measured TEER in the cellZscope device as described above. In accordance with the increased TJ protein expression levels, we observed significantly increased TEER values by approximately 30% in mice lacking Mep1b compared to wt animals, indicating a tighter BBB in the absence of Mep1b (Figure 4). As Mep1b overexpression and Mep1b knock-out showed a directly opposed response regarding the TJ protein expression and TEER values, we suggest that Mep1b could be a relevant protease in regulating TJ composition and barrier integrity in brain endothelium.

Figure 4.

Elevated TEER in primary mouse brain endothelial cells (pMBCECs) from Mep1b^−/− mice. Isolated pMBCECs from Mep1b^−/− and wt mice were cultivated on transwell inserts in the cellZcope device. TEER values were measured as described for bEnd.3 cells above. Transendothelial electrical resistance (TEER) measurement of Mep1b wt pMBCECs compared to Mep1b^−/− pMBCECs. TEER values of Mep1b wt pMBCECs were set as 100%. Maximum TEER values were >50 Ωcm² (Mep1b wt) and >65 Ωcm² (Mep1b^−/−). One representative set of data dot plots and mean ± standard deviation of n = 24 (Mep1b wt) and n = 24 (Mep1b^−/−) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001.

Soluble Mep1b is potent to regulate claudin-5 in vitro

The effects of the lack of Mep1b on TEER values in primary cultured endothelial cells of Mep1b^−/− and wt mice suggested that endothelial-derived Mep1b influenced the TJ composition in brain endothelial cells. However, secreted factors by every other cell of the neurovascular unit as well as the composition of the basement membrane can influence BBB integrity.^14,29–31 In order to see whether soluble Mep1b present in the various body fluids secreted by other non-endothelial cells is potent to regulate TJ proteins, we treated primary porcine endothelial cells with 5 μM recombinant Mep1b for 24 h. Interestingly, we found that the presence of soluble Mep1b in the cell culture media reduced the level of claudin-5 in primary porcine endothelial cells compared to untreated controls (Figure 5(a)).

Figure 5.

Decrease of claudin-5 expression in soluble Mep1b-treated endothelial cells. (a) Immunostaining of claudin-5 in lysates of 5 µM soluble Mep1b-treated primary porcine brain endothelial cells and control cells. Anti-β actin is shown as loading control. (b) Immunostaining of claudin-5 in lysates of 5 µM soluble Mep1b + 10 µM actinonin-treated bEnd.3 cells, control bEnd.3 cells and 5 µM soluble Mep1b-treated bEnd.3 cells. Anti-β actin is shown as loading control. (c) Claudin-5 levels were quantified by densitometric analysis of Western blots. Intensities of control bEnd.3 cells were set as 100%. Data represent dot plots and mean ± standard deviation of n = 2 biological replicates per group. For statistical analyses, one-way ANOVA followed by Tukey’s post hoc test was used. *P < 0.05, **P < 0.01, ***P < 0.001.

Similarly, bEnd.3 cells treated with 5 μM recombinant Mep1b showed a significant reduction of full length claudin-5 by approximately 50% compared to untreated bEnd.3 cells. The Mep1b effect on claudin-5 expression could be rescued by simultaneous application of actinonin, a meprin inhibitor (Figure 5(b) and (c)). Therefore, our data suggested that not only endothelial-derived Mep1b but also secreted Mep1b by other cells can influence TJ proteins in brain endothelial cells.

Reduced levels of IgG in CSF of Mep1b^−/− mice

As we observed that Mep1b affects both TJ composition and BBB integrity, we wanted to know whether there is also an effect of the Mep1b knock-out on BBB permeability in vivo. Hence, we analyzed the IgG protein levels CSF which we gained by cisterna magna puncture from global Mep1b^−/− and wt mice. IgG antibodies are too large to cross the BBB in high amounts and have widely been used to measure the penetration of large blood-derived molecules into brain.^8,32 Thus, we considered IgG levels in CSF as a suitable in vivo BBB permeability marker. The CSF surrounds the brain in the ventricles and is constantly mixed with interstitial brain fluid⁸ by CSF influx into brain parenchyma and is therefore a representative compartment for the analysis of paracellular passage of substances from the blood in the CNS.³³

Investigating the CSF of mice lacking Mep1b, we found a significant decrease in IgG levels by approximately 50% compared to wt animals (Figure 6(a) and (b)). These data are in line with the increased TJ protein levels and TEER values, indicating an elevated tightness of BBB in Mep1b^−/− mice resulting in reduced permeability to a high molecular protein like IgG.

Figure 6.

Reduced levels of IgG in CSF of Mep1b^−/− mice. To monitor BBB integrity in Mep1b^−/− and wt mice, CSF samples for IgG content were analyzed. (a) Representative immunostaining of IgG in CSF of Mep1b wt compared to Mep1b^−/− mice. (b) IgG levels in CSF were quantified by densitometric analysis of Western blots. Intensities of Mep1b wt CSF were set as 100%. Data represent dot plots and mean ± standard deviation of n = 13 (Mep1b wt) and n = 14 (Mep1b^−/−) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001.

Brain water content in Mep1b^−/− mice is significantly altered

A breakdown of the BBB includes a structural disruption of the TJ and increased paracellular permeability, which is a common feature of several CNS disorders, including acute and chronic neurodegenerative diseases, such as AD, PD, HD, ALS or MS.⁸ This can lead to an extensive influx of hematogenous fluid into the extravascular space, resulting in an increased brain water content, which is a marker for brain swelling.⁷ Since we observed in Mep1b^−/− mice altered BBB characteristics as elevated TJ protein levels, increased TEER and decreased permeability of blood-derived molecules, we examined whether Mep1b ablation also affects the brain water homeostasis. Therefore, we investigated the brain water content in global Mep1b^−/− mice compared to wt mice. In brains of Mep1b^−/− mice, we found a significant decrease of brain water content by approximately 1.6% compared to wt controls (Figure 7(a)). This difference of 1.6% is relevant to brain water homeostasis in vivo, since the brain water content shows a nearly exponential relation to brain swelling.¹² Hence, our data provide evidence that knock-out of Mep1b leads to reduced brain water content, which may be a consequence of the elevated tightness of the BBB due to increased TJ protein levels in Mep1b^−/− mice.

Figure 7.

Decreased brain water content in Mep1b^−/− mice. (a) To analyse BBB integrity in Mep1b^−/− and wt mice, brain water content was determined. Brains of Mep1b^−/− and wt mice were weighed and then dried overnight at 100°C. The dried brains were re-weighed and brain water content calculated as (wet weight–dry weight) × 100/wet weight. The net change in brain water in Mep1b^−/− mice was normalized to wt controls. Data represent dot plots and mean ± standard deviation of n = 6 (Mep1b wt) and n = 13 (Mep1b^−/−) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001. (b–c) Determination of ventricle size in Mep1b^−/− and wt mice. (b) Representative brain slides of third and lateral ventricles of Mep1b^−/− and wt mice. (c) At similar coronal sections, area of lateral ventricles and third ventricle were examined under a microscope and values were normalized to the mean of the wt mice. Data represent dot plots and mean ± standard deviation of n = 3 (Mep1b wt) and n = 3 (Mep1b^−/−) biological replicates. For statistical analyses, unpaired t test was used. *P < 0.05, **P < 0.01, ***P < 0.001.

To investigate whether the reduction in brain water content in Mep1b^−/−mice is also associated with ventricle shrinkage, we analyzed brain slices of Mep1b^−/− and wt mice and measured the size of the third and the lateral ventricle. However, we could not find significant differences between Mep1b^−/− mice and controls suggesting that Mep1b expression and the parallel differences in brain water do not affect the development of brain ventricle morphology (Figure 7(b) and (c)).

Discussion

Mep1b is a predominantly membrane bound metalloprotease which was originally found to be highly expressed in kidney and intestine.¹ Hence, research focused on those organ specific functions implicating Mep1b in inflammatory bowel disease and acute kidney failure. Over the last years, a much broader expression pattern of Mep1b has been detected.^1,22 We reported elevated Mep1b transcription levels in the brain of AD patients, where it may contribute to increased Aβ-peptide generation.¹⁶ It has been shown that Mep1b is capable of cleaving cell-adhesion molecules in different tissues (e.g. skin, kidney, intestine),^1,2,4,5 which is in line with dysregulation of Mep1b in diseases associated with barrier breakdown (AD, kidney disruption, inflammatory bowel disease).^20–22 Therefore, we investigated the potential influence of Mep1b on TJ function and BBB integrity in brain endothelium in vitro and in vivo.

In the present study, we demonstrate that Mep1b overexpression in mouse brain endothelial cells (bEnd.3) leads to decreased claudin-5 expression levels, which correlated with decreased TEER values and an elevated permeability to [C¹⁴]-inulin in an in vitro transwell system, indicating an impairment of the BBB in vitro. Additionally, we observed elevated TJ proteins, increased TEER values, decreased IgG levels in the CSF and a reduced brain water content in mice globally lacking Mep1b, suggesting that a knock-out of Mep1b results in a tighter BBB with a greater integrity. Since Mep1b overexpressing bend.3 cells and Mep1b^−/− mice showed a directly opposed response regarding fundamental BBB characteristics, that is TJ protein expression, TEER and permeability, we propose that Mep1b acts as a protease relevant in regulating TJ composition and barrier integrity in brain endothelium in vivo.

To determine whether Mep1b expression influences TJ function in vitro, we generated stable Mep1b overexpressing endothelial cells (bEnd.3). We observed a 50% reduction in claudin-5 protein expression in the Mep1b overexpressing bEnd.3 cells, indicating a detrimental effect of Mep1b on TJ protein level in vitro accompanied with lower TEER and higher permeability of paracellular tracers. Similar observations have been reported by Chen et al.³⁴ when they transfected bEnd.3 cells with matrix metalloproteinase-9 (MMP-9), which resulted in decreased TJ protein levels (claudin-5, occludin, ZO-1, ZO-2) and impairment of BBB permeability. MMP-9 is a member of the family of matrix metalloproteinases that has been shown to degrade occludin and claudin-5 in focal cerebral ischemia resulting in BBB opening.^35,36 In mice where murine ApoE was replaced with the human isoform of APOE4, a major genetic risk factor for AD, it has been shown that BBB leakage is caused by an upregulation of MMP-9 due to a lack of ApoE4 signaling. Moreover, these effects could be reversed by MMP inhibitor treatment or MMP-9 short interfering (si)RNA administration into the hippocampus of these mice.²⁹ Whereas MMP function in general and its role in BBB breakdown during stroke (MMP-9, MMP-2) or AD have been intensively studied, the physiological functions of the metalloprotease Mep1b are still in many cases elusive.¹

Since we observed similar effects as reported for other MMPs³⁶ by Mep1b overexpression on TJ composition in bEnd.3 cells, we suggest that Mep1b may have a comparable influence on BBB integrity. In contrast to MMP-9, which was demonstrated to degrade occludin and claudin-5,³⁵ we have not deciphered the exact mechanism of action yet how Mep1b influences the TJ expression. One way of action could be a direct mechanism, whereby the Mep1b sheds junctional proteins, therefore compromising BBB integrity. This is supported by Western blot analysis and peptide cleavage assays. Another possibility is that Mep1b acts via an indirect mechanism by activation of other proteases or signaling cascades that in turn influences junctional protein expression including claudin-5.

Interestingly, in brain microvessels, Mep1b expression not only showed effects on TJ proteins sealing the paracellular space (claudin-5, occludin) but also on the intracellular protein ZO-1. As both membrane-bound and soluble Mep1b does not have access to intracellular ZO-1, it might be plausible that Mep1b cleavage of claudin-5 or occludin leads to the internalization of the whole TJ complex. However, further studies will be necessary to understand how Mep1b affects intracellular proteins like ZO-1 or whether other intracellular proteins of the TJ complex are affected as well.

Moreover, it remains to be seen whether the observed in vivo effects of Mep1b on BBB integrity are due to endothelial Mep1b or secreted Mep1b released by other cells. It has been shown that pericytes^14,29,30 or the composition of the basement membrane³¹ influence BBB integrity. However, also circulating cells in the blood or soluble Mep1b in the body fluids could alter BBB permeability.³⁷ The effects that we observed on TEER in endothelial cells cultured in the presence of puromycin, which kills non-endothelial cells due to their lack of ABC transporters, suggest that brain endothelial-derived Mep1b is potent to influence TJ protein levels.³⁸ However, we were not able to detect Mep1b in brain microvessels via Western blot analysis with several different antibodies. In our hands, these antibodies easily detect Mep1b in kidney lysates but so far we have been unable to see specific signals in brain microvessels or whole brain lysates. In the brain, we have reported Mep1b transcription by RT PCR analysis.⁶ Another plausible effect for the lack of Mep1b protein detection is its low expression in brain microvessels. Single cell analysis of vascular cells in the brain revealed that only very few of the total amount of analysed endothelial cells expressed Mep1b.^39,40 The expression of Mep1b was restricted to specific subtypes of endothelial cells (termed as endothelial cells type 2 or arterial endothelial cells) suggesting a regional heterogeneity of Mep1b in the vasculature of the brain. This is in line with previously published bulk RNA data from another group that showed general low Mep1b expression in brain vasculature and also with the Mep1b activity data that we gathered from isolated whole brain vessels showing a slight but significant elevation of Mep1b activity in brain vessels from Mep1b wt mice compared to Mep1b^−/− mice.⁴¹ Overall, several lines of evidence from us and others suggest a low expression of Mep1b in brain vasculature.

Nevertheless, we also provide evidence that soluble Mep1b in the various body fluids could alter BBB integrity in vivo. Both, Mep1b-treated bEnd.3 cells and primary porcine endothelial cells showed reduced claudin-5 levels compared to untreated control cells. In bEnd.3 cells, the effect of Mep1b on TJ proteins effect could also be rescued by the addition of the Mep1b inhibitor actinonin. These results suggest that soluble Mep1b released by non-endothelial cells in the periphery or brain, present in blood and interstitual fluid or CSF, are potent to influence TJ protein levels in the brain. These findings go along with a report showing that the deletion of the Mep1 gene in leukocytes diminishes the ability of them to disseminate through the extracellular matrix indicating that Mep1b expressed by non-endothelial cells influences barrier-dependent processes like transendothelial migration.³⁷ Given that there is evidence that Mep1b effects on TJ and BBB integrity can both be attributed to endothelial Mep1b and Mep1b released by other cells, we believe that during disease both sources could contribute to BBB impairment.

Claudin-5 and occludin are two of the major TJ proteins in brain microvessels and are dysregulated in many neurological disorders such as multiple sclerosis, stroke, Alzheimer’s disease, small vessel disease, during CNS invasion of cancers and during infection.^42,43 Mice lacking occludin appear to have morphologically unaltered TJs but show a complex phenotype with postnatal growth retardation and brain calcification.⁴⁴ In contrast, claudin-5 deficient mice die within 10 h after birth and show a massive BBB impairment along with leakage of high molecular molecules of up to 800 Dalton.⁴⁵ Interestingly, double knockdown of claudin-5 and occludin even enhanced the permeation of tracer molecules up to a size of 3000 to 10,000 Da.⁴⁶ In our study, both claudin-5 and occludin were affected by Mep1b expression along with higher IgG levels in the CSF suggesting that the loss of TJ proteins enhances brain penetration of IgG from blood.

In vivo BBB integrity was further investigated by analysis of brain water content in Mep1b^−/− and wt mice. Our data showed a decrease of 1.6% in brain water content in the Mep1b^−/− mice compared to wt controls that were used for normalization. This represents a dramatic difference, as such values have been observed in rat brains with focal ischemia or in mice with traumatic brain injury.^12,47 Keep et al. for example reported an absolute difference of 1.3% in brain water content in rat brains with ischemia compared to controls. This reflects a normalized difference of 1.68% to control brains which is slightly higher than the difference we observed between Mep1b^−/− and wt mice.¹² Small changes in brain water content reflect large changes in brain swelling, since the relation between those two factors is not linear but nearly exponential and a massive brain edema usually results in irreversible neurodegeneration.¹¹ The reduced brain water content in Mep1b^−/− mice is consistent with our previous observations in integrity and permeability of BBB, all indicating an elevated BBB tightness, which restricts the paracellular water influx from blood into brain in Mep1b^−/− mice. Interestingly, the difference in brain water content was not accompanied by a significant difference in brain ventricle size as determined by measuring the lateral and third ventricle. This suggests that Mep1b deficiency does not alter the morphology of ventricles of the brain.

Taken together, Mep1b overexpression in bEnd.3 cells in vitro and Mep1b knock-out in vivo showed opposing features in BBB integrity like TJ composition, TEER and permeability demonstrating that Mep1b is a novel regulator of TJ composition and BBB integrity in brain endothelium. Further investigations are needed to understand the relevance and exact mechanism of Mep1b influence on BBB integrity.

Supplemental Material

JCB905206 Supplemental Material - Supplemental material for Meprin β: A novel regulator of blood–brain barrier integrity

Supplemental material, JCB905206 Supplemental Material for Meprin β: A novel regulator of blood–brain barrier integrity by Markus Gindorf, Steffen E Storck, Anke Ohler, Franka Scharfenberg, Christoph Becker-Pauly and Claus U Pietrzik in Journal of Cerebral Blood Flow & Metabolism

Footnotes

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB877, “Proteolysis as a Regulatory Event in Pathophysiology” (A9, A15). MG would like to thank the Integrated Research Training Group (IRTG) of SFB877 for financial support. This work comprises substantial parts of the dissertation of Markus Gindorf.

Acknowledgements

The authors thank Johanna Wesselowski for excellent technical assistance.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Authors’ contributions

MG and SES, as the first authors, designed the studies, conducted the experiments, and wrote the manuscript. AO contributed to the experimental design of the study and performed experiments. FS conducted the activity assays. FS, CB and CUP helped write the manuscript. CUP supervised the experimental design and entire work of the manuscript. All authors read and approved the final manuscript.

Supplemental material

Supplemental material for this article is available online.

ORCID iDs

Markus Gindorf

Steffen E Storck

References

Broder

Becker-Pauly

The metalloproteases meprin alpha and meprin beta: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis. Biochem J 2013; 450: 253–264.

Jefferson

Auf dem Keller

Bellac

, et al. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin beta and ADAM10. Cell Mol Life Sci 2013; 70: 309–333.

Becker-Pauly

Pietrzik

CU.

The metalloprotease meprin beta is an alternative beta-secretase of APP.

Front Mol Neurosci 2016; 9: 159.

Ambort

Brellier

Becker-Pauly

, et al. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading. Matrix Biol 2010; 29: 31–42.

Huguenin

Muller

Trachsel-Rosmann

, et al. The metalloprotease meprinbeta processes E-cadherin and weakens intercellular adhesion. PLoS One 2008; 3: e2153.

Jefferson

Causevic

auf dem Keller

, et al. Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J Biol Chem 2011; 286: 27741–27750.

Jiang

Andjelkovic

Zhu

, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 2018; 163–164: 144–71.

Palmer

AM.

The role of the blood-CNS barrier in CNS disorders and their treatment. Neurobiol Dis 2010; 37: 3–12.

Lok

Gupta

Guo

, et al. Cell-cell signaling in the neurovascular unit. Neurochem Res 2007; 32: 2032–2045.

10.

Bauer

Krizbai

Bauer

, et al. “You Shall Not Pass”-tight junctions of the blood brain barrier. Front Neurosci 2014; 8: 392.

11.

Prakash

Carmichael

ST.

Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. Curr Opin Neurol 2015; 28: 556–564.

12.

Keep

Hua

Brain water content. A misunderstood measurement?

Transl Stroke Res 2012; 3: 263–265.

13.

DiSabato

Quan

Godbout

JP.

Neuroinflammation: the devil is in the details. J Neurochem 2016; 139(Suppl 2): 136–153.

14.

Halliday

Rege

, et al. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J Cereb Blood Flow Metab 2016; 36: 216–227.

15.

Cramer

Modvig

Simonsen

, et al. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain 2015; 138(Pt 9): 2571–2583.

16.

Schonherr

Bien

Isbert

, et al. Generation of aggregation prone N-terminally truncated amyloid beta peptides by meprin beta depends on the sequence specificity at the cleavage site. Mol Neurodegener 2016; 11: 19.

17.

Storck

Meister

Nahrath

, et al. Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier. J Clin Invest 2016; 126: 123–136.

18.

Storck

Hartz

AMS

Bernard

, et al. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM. Brain Behav Immun 2018; 73: 21–33.

19.

Meister

Storck

Hameister

, et al. Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model. J Cereb Blood Flow Metab 2015; 35: 1112–1121.

20.

DeMattos

Bales

Parsadanian

, et al. Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer’s disease. J Neurochem 2002; 81: 229–236.

21.

Jodal

Pape

Becker-Pauly

, et al. Evaluation of (1)(1)(1)in-labelled exendin-4 derivatives containing different meprin beta-specific cleavable linkers. PLoS One 2015; 10: e0123443.

22.

Bond

Matters

Banerjee

, et al. Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Lett 2005; 579: 3317–3322.

23.

Bien

Jefferson

Causevic

, et al. The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species. J Biol Chem 2012; 287: 33304–33313.

24.

Medoro

Bartollino

Mignogna

, et al. Proteases upregulation in sporadic Alzheimer’s disease brain. J Alzheimers Dis 2019; 68: 931–938.

25.

Bicker

Alves

Fortuna

, et al. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. Eur J Pharm Biopharm 2014; 87: 409–432.

26.

Heidari

Taylor

Review article: capturing the physiological complexity of the brain’s neuro-vascular unit in vitro. Biomicrofluidics 2018; 12: 051502.

27.

Wichert

Scharfenberg

Colmorgen

, et al. Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage. FASEB J 2019; 33: 11925–11940.

28.

Andrews

Lutton

Cannella

, et al. Characterization of human fetal brain endothelial cells reveals barrier properties suitable for in vitro modeling of the BBB with syngenic co-cultures. J Cereb Blood Flow Metab 2018; 38: 888–903.

29.

Bell

Winkler

Singh

, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012; 485: 512–516.

30.

Shen

Zhu

, et al. PDGFR-beta restores blood-brain barrier functions in a mouse model of focal cerebral ischemia. J Cereb Blood Flow Metab 2019; 39: 1501–1515.

31.

Yao

Basement membrane and stroke. J Cereb Blood Flow Metab 2019; 39: 3–19.

32.

Cristante

McArthur

Mauro

, et al. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A 2013; 110: 832–841.

33.

Iliff

Wang

Liao

, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012; 4: 147ra11.

34.

Chen

Ohashi

, et al. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 2009; 50: 1914–1923.

35.

Yang

Estrada

Thompson

, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007; 27: 697–709.

36.

Nag

Kapadia

Stewart

DJ.

Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 2011; 37: 3–23.

37.

Crisman

Zhang

Norman

, et al. Deletion of the mouse meprin beta metalloprotease gene diminishes the ability of leukocytes to disseminate through extracellular matrix. J Immunol 2004; 172: 4510–4519.

38.

Perriere

Demeuse

Garcia

, et al. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem 2005; 93: 279–289.

39.

Vanlandewijck

Mae

, et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types. Sci Data 2018; 5: 180160.

40.

Vanlandewijck

Mae

, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 2018; 554: 475–480.

41.

Zhang

Chen

Sloan

, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 2014; 34: 11929–11947.

42.

Chiu

Lai

SC.

Matrix metalloproteinase-9 leads to claudin-5 degradation via the NF-kappaB pathway in BALB/c mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis. PLoS One 2013; 8: e53370.

43.

Zhu

, et al. Circulating tight junction proteins mirror blood-brain barrier integrity in leukaemia central nervous system metastasis. Hematol Oncol 2017; 35: 365–373.

44.

Greene

Campbell

Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers 2016; 4: e1138017.

45.

Nitta

Hata

Gotoh

, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161: 653–660.

46.

Greene

Hanley

Campbell

Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS 2019; 16: 3.

47.

Yuan

, et al. Mild hypothermia alleviates brain oedema and blood-brain barrier disruption by attenuating tight junction and adherens junction breakdown in a swine model of cardiopulmonary resuscitation. PLoS One 2017; 12: e0174596.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.62 MB

Meprin β: A novel regulator of blood–brain barrier integrity

Abstract

Keywords

Introduction

Material and methods

Mice

Cell culture and antibodies

Generation of stably overexpressing meprin β bEnd.3 cells

Isolation and cultivation of primary mouse and porcine brain capillary endothelial cells

Treatment of cells with soluble Mep1b

Determination of ventricle size

Transendothelial electrical resistance studies

Cerebral vessel isolation

CSF isolation

Cell extraction and Western blot analysis

Brain water content

Activity assays

Statistical analysis

Results

The expression of TJ protein claudin-5 is decreased in Mep1b-overexpressing endothelial bEnd.3 cells

Overexpression of Mep1b leads to an impaired barrier integrity in bEnd.3 cells

Increased TJ protein levels in cerebral microvessels of Mep1b−/− mice

Elevated TEER in primary mouse brain endothelial cells from Mep1b−/− mice

Soluble Mep1b is potent to regulate claudin-5 in vitro

Reduced levels of IgG in CSF of Mep1b−/− mice

Brain water content in Mep1b−/− mice is significantly altered

Discussion

Supplemental Material

JCB905206 Supplemental Material - Supplemental material for Meprin β: A novel regulator of blood–brain barrier integrity

Footnotes

Funding

Acknowledgements

Declaration of conflicting interests

Authors’ contributions

Supplemental material

ORCID iDs

References

Supplementary Material

Increased TJ protein levels in cerebral microvessels of Mep1b^−/− mice

Elevated TEER in primary mouse brain endothelial cells from Mep1b^−/− mice

Reduced levels of IgG in CSF of Mep1b^−/− mice

Brain water content in Mep1b^−/− mice is significantly altered